Comparison between objective measures of smoking and self-reported smoking status in patients with asthma or COPD: are our patients telling us the truth?*
نویسندگان
چکیده
OBJECTIVE Smoking prevalence is frequently estimated on the basis of self-reported smoking status. That can lead to an underestimation of smoking rates. The aim of this study was to evaluate the difference between self-reported smoking status and that determined through the use of objective measures of smoking at a pulmonary outpatient clinic. METHODS This was a cross-sectional study involving 144 individuals: 51 asthma patients, 53 COPD patients, 20 current smokers, and 20 never-smokers. Smoking status was determined on the basis of self-reports obtained in interviews, as well as through tests of exhaled carbon monoxide (eCO) and urinary cotinine. RESULTS All of the asthma patients and COPD patients declared they were not current smokers. In the COPD and asthma patients, the median urinary cotinine concentration was 167 ng/mL (range, 2-5,348 ng/mL) and 47 ng/mL (range, 5-2,735 ng/mL), respectively (p < 0.0001), whereas the median eCO level was 8 ppm (range, 0-31 ppm) and 5 ppm (range, 2-45 ppm), respectively (p < 0.05). In 40 (38%) of the patients with asthma or COPD (n = 104), there was disagreement between the self-reported smoking status and that determined on the basis of the urinary cotinine concentration, a concentration > 200 ng/mL being considered indicative of current smoking. In 48 (46%) of those 104 patients, the self-reported non-smoking status was refuted by an eCO level > 6 ppm, which is also considered indicative of current smoking. In 30 (29%) of the patients with asthma or COPD, the urinary cotinine concentration and the eCO level both belied the patient claims of not being current smokers. CONCLUSIONS Our findings suggest that high proportions of smoking pulmonary patients with lung disease falsely declare themselves to be nonsmokers. The accurate classification of smoking status is pivotal to the treatment of lung diseases. Objective measures of smoking could be helpful in improving clinical management and counseling.
منابع مشابه
تأثیر مشاوره بر ترک سیگار بیماران مبتلا به بیماریهای مزمن انسدادی ریه
Background & Aim: Cigarette smoking is the primary risk factor for COPD (chronic obstructive pulmonary diseases). Smoking cessation is the most effective strategy for prevention or treatment of COPD. Counseling is a efficacious method for smoking cessation. One of the nurses’ roles is counseling that they can use it in patients’ care. The aim of this study is evaluating the effects of counselin...
متن کاملHealth-Related Quality of Life and Related Factors in Patients With Chronic Obstructive Pulmonary Disease
Background: Chronic Obstructive Pulmonary Disease (COPD) affects different aspects of patients’ life. By awareness of the quality of life and related factors of each patient, nurses can plan for and do proper care. So the present study was performed to evaluate health-related quality of life and related factors in patients with COPD. Methods: This study is a cross-sectional descriptive r...
متن کاملValidation of smoking cessation self-reported by patients with chronic obstructive pulmonary disease
PURPOSE The present study reports on the biochemical validation of the self-reported smoking status of patients with chronic obstructive pulmonary disease (COPD). The objective is to establish the proportion of overestimation of self-reported success rates. METHODS A cross-sectional smoking-status validation study including 60 patients with COPD who reported that they had stopped smoking. In ...
متن کاملبررسی مقایسهای مصرف سیگار در بیماران پسوریازیس ولگاریس و گروه کنترل سالم
800x600 Normal 0 false false false EN-US X-NONE AR-SA MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal" mso-tstyle-rowband-size:0 mso-tstyle-colband-size:0 mso-style-noshow:yes mso-style-priority:99 mso-style-parent:"" mso-p...
متن کاملComparison of the effect of broncodiatory albotrol from spacer and nebulazor foe freatment of Astma patients
Tavana S1, Nadi E1, Ansari M2, zeraati F3, Hashemi H1, Mani Kashani Kh4, Mavallat M5 1. Assistant professor, Department of internal, Faculty of medicine, Hamedan University of medical sciences 2. Associate professor, Department of internal, Faculty of medicine, Hamedan University of medical sciences 3. Associate professor, Department of Pharmacology, Faculty of medicine, Hamedan Univers...
متن کامل